Likely catalyst: People pass a Genting signage at a hotel in Singapore. The potential listing of Genting’s 20.7-owned TauRx on Nasdaq may provide a catalyst to Genting’s share price. – Reuters
Casino operator may gain from share in drug company
PETALING JAYA: The potential listing of Genting Bhd
’s 20.7%-owned Alzheimer’s drugs company on Nasdaq could provide a catalyst to the share price of the Malaysian conglomerate.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
